News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,808 Results
Type
Article (1648)
Company Profile (9)
Press Release (36151)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (15540)
Career Advice (126)
Deals (2314)
Drug Delivery (1)
Drug Development (3725)
Employer Resources (1)
FDA (573)
Job Trends (786)
News (21246)
Policy (1142)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (48)
Accelerated approval (3)
Allergies (9)
Alliances (1227)
ALS (11)
Alzheimer's disease (62)
Antibody-drug conjugate (ADC) (21)
Approvals (643)
Artificial intelligence (11)
Autoimmune disease (12)
Automation (2)
Bankruptcy (5)
Best Places to Work (740)
Biosimilars (7)
Biotechnology (6)
Bladder cancer (10)
Breast cancer (41)
Cancer (303)
Cardiovascular disease (45)
Career advice (124)
Career pathing (1)
CAR-T (9)
Cell therapy (23)
Cervical cancer (2)
Clinical research (3486)
Collaboration (55)
Compensation (16)
COVID-19 (70)
CRISPR (5)
C-suite (11)
Cystic fibrosis (18)
Data (476)
Depression (6)
Dermatology (5)
Diabetes (39)
Diagnostics (302)
Digital health (4)
Drug discovery (8)
Drug pricing (4)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (14713)
Employer resources (1)
Events (3839)
Executive appointments (6)
FDA (893)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (42)
Gene editing (13)
Gene therapy (18)
GLP-1 (46)
Government (93)
Guidances (166)
Healthcare (907)
HIV (2)
IgA nephropathy (14)
Immunology and inflammation (10)
Indications (13)
Infectious disease (96)
Inflammatory bowel disease (10)
Influenza (2)
Intellectual property (10)
Interviews (12)
IPO (1667)
Job creations (92)
Job search strategy (114)
JPM (1)
Labor market (4)
Layoffs (14)
Legal (195)
Liver cancer (7)
Longevity (1)
Lung cancer (42)
Lymphoma (41)
Machine learning (2)
Management (1)
Manufacturing (20)
MASH (9)
Medical device (813)
Medtech (818)
Mergers & acquisitions (693)
Metabolic disorders (74)
mRNA (3)
Multiple sclerosis (7)
Neurodegenerative disease (19)
Neuropsychiatric disorders (4)
Neuroscience (130)
NextGen: Class of 2026 (192)
Non-profit (83)
Now hiring (1)
Obesity (24)
Opinion (4)
Ovarian cancer (5)
Pain (13)
Pancreatic cancer (5)
Parkinson's disease (8)
Patents (15)
Patient recruitment (21)
Peanut (4)
People (1060)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase 1 (846)
Phase 2 (1350)
Phase 3 (1489)
Pipeline (976)
Policy (2)
Postmarket research (180)
Preclinical (271)
Press Release (1)
Prostate cancer (25)
Radiopharmaceuticals (10)
Rare diseases (56)
Real estate (154)
Regulatory (1090)
Reports (4)
Research institute (50)
Resumes & cover letters (10)
Rett syndrome (1)
RSV (17)
Schizophrenia (8)
Series A (10)
Series B (6)
Sickle cell disease (11)
Spinal muscular atrophy (11)
Sponsored (1)
Startups (93)
Supply chain (1)
Tariffs (2)
The Weekly (1)
Vaccines (21)
Venture capital (5)
Weight loss (15)
Women's health (4)
Date
Today (3)
Last 7 days (23)
Last 30 days (132)
Last 365 days (2063)
2026 (571)
2025 (2008)
2024 (2236)
2023 (2389)
2022 (3550)
2021 (4092)
2020 (3474)
2019 (1831)
2018 (1318)
2017 (1139)
2016 (718)
2015 (1181)
2014 (784)
2013 (418)
2012 (514)
2011 (683)
2010 (642)
Location
Africa (67)
Alabama (13)
Arizona (14)
Asia (2162)
Australia (317)
California (849)
Canada (201)
China (63)
Colorado (43)
Connecticut (28)
Delaware (46)
Europe (4351)
Florida (115)
Georgia (28)
Idaho (3)
Illinois (62)
India (2)
Indiana (40)
Japan (38)
Kansas (4)
Kentucky (6)
Louisiana (7)
Maine (9)
Maryland (104)
Massachusetts (543)
Michigan (23)
Minnesota (53)
Missouri (8)
Montana (2)
Nevada (3)
New Hampshire (5)
New Jersey (296)
New Mexico (1)
New York (205)
North Carolina (76)
Northern California (452)
Ohio (18)
Oregon (1)
Pennsylvania (196)
Rhode Island (1)
South America (73)
Southern California (348)
Tennessee (7)
Texas (104)
United States (2936)
Utah (24)
Virginia (6)
Washington D.C. (5)
Washington State (61)
Wisconsin (10)
37,808 Results for "105".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
February 8, 2026
·
3 min read
Press Releases
Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease
March 5, 2026
·
3 min read
Press Releases
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
March 23, 2026
·
5 min read
Press Releases
KangaBio Announces FDA IND Clearance for KGX105, AACR Acceptance of KGX101 Clinical Data Abstract, and Completion of Over $15 Million in Pre-A+ Financing
March 2, 2026
·
1 min read
Press Releases
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
January 5, 2026
·
3 min read
Press Releases
Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
March 16, 2026
·
14 min read
Press Releases
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
October 23, 2025
·
6 min read
Press Releases
March Biosciences Announces Oral Presentation of MB-105 Interim Phase 2 Clinical Data at American Society of Hematology Annual Meeting
November 4, 2025
·
3 min read
Press Releases
March Biosciences Presents Positive Interim Clinical Data from Phase 2 Trial of MB-105 CD5 CAR-T Cell Therapy at ASH 2025 Annual Meeting
December 9, 2025
·
4 min read
Press Releases
Kairos Pharma Presents on Phase 2 Trial of ENV-105 in Advanced Prostate Cancer at European Society Medical Oncologists (ESMO) Meeting
October 21, 2025
·
4 min read
1 of 3,781
Next
